Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20150123003Phase 2Completed
Phase 2, randomised, double-blind trial in allergic rhinitis (AR) (2 arms), sponsored by Thai Traditional Medicine Knowledge Fund. Primary endpoints: Safety profile and Efficacy in persistent allergic rhinitis. Started Feb 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20150123003.